3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
23
Phase NA
17
Phase 1/2
8
Phase 1
7
Phase 3
3
Phase EARLY_PHASE1
2
Phase 2/3
1
Status
Completed
4
Withdrawn
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
5
Head and Neck Neoplasms
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms, Squamous Cell
2
Glioblastoma
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Incontinence
1
Tuberous Sclerosis
1
Sarcoma
1
Recurrent respiratory papillomatosis
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Papillomavirus Infections
1
Papilloma
1
Ovarian Neoplasms
1
Orgasm
1
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Melanoma
1
Medication Adherence
1
Interventions
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Withdrawn
×
Carcinoma, Renal Cell
×
Clear all
NCT07084909
2025-12-10
HARRIER
Lantheus Medical Imaging
Phase 2/3
Withdrawn